IMAGE: Journal of Women’s Health is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well as diseases… view more
Credit: Mary Ann Liebert, Inc., publishers
New Rochelle, NY, August 23, 2018–A new study has found that physicians with nonprofessional experience of cancer were less likely to report adhering to recommendations against screening for ovarian cancer compared with physicians without this experience. Reported adherence to ovarian cancer screening guidelines was defined as almost never ordering or offering ovarian cancer screening tests for an asymptomatic patient at average risk for ovarian cancer. The study findings are presented in an article published in Journal of Women’s Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. Click here to read the full-text article free on the Journal of Women’s Health website through September 23, 2018.
Margaret Ragland, MD, MS and colleagues from the University of Washington (Seattle) and the Centers for Disease Control and Prevention (Atlanta, GA) coauthored the article entitled, “Physician Nonprofessional Cancer Experience and Ovarian Cancer Screening Practices: Results from a National Survey of Primary Care Physicians.” They conducted a survey of US physicians who provide primary care to women and examined the association between physicians’ experience with cancer in a nonprofessional setting and reported adherence to ovarian cancer screening guidelines. The researchers indicate that strategies need to be developed to ensure that the ovarian cancer screening practices of physicians with nonprofessional experience of cancer reflect evidence-based recommendations.
“Screening for ovarian cancer is not recommended for asymptomatic average-risk women, and offering or ordering non-recommended screening exposes these women to unnecessary risk,” states Susan G. Kornstein, MD, Editor-in-Chief of Journal of Women’s Health and Executive Director of the Virginia Commonwealth University Institute for Women’s Health, Richmond, VA. “The findings of this study emphasize the need for physicians to be aware of factors that may influence their screening practices and to ensure that all physicians adhere to ovarian cancer screening guidelines.”
About the Journal
Journal of Women’s Health, published monthly, is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well as diseases that present differently in women. Led by Editor-in-Chief Susan G. Kornstein, MD, Executive Director of the Virginia Commonwealth University Institute for Women’s Health, Richmond, VA, and President of the Academy of Women’s Health, the Journal covers the latest advances and clinical applications of new diagnostic procedures and therapeutic protocols for the prevention and management of women’s healthcare issues. Complete tables of content and a sample issue may be viewed on the Journal of Women’s Health website. Journal of Women’s Health is the official journal of the Academy of Women’s Health and the Society for Women’s Health Research.
About the Academy
Academy of Women’s Health is an interdisciplinary, international association of physicians, nurses, and other health professionals who work across the broad field of women’s health, providing its members with up-to-date advances and options in clinical care that will enable the best outcomes for their women patients. The Academy’s focus includes the dissemination of translational research and evidence-based practices for disease prevention, diagnosis, and treatment of women across the lifespan.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including LGBT Health, Transgender Health, Population Health Management, and Breastfeeding Medicine. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 80 journals, books, and newsmagazines is available on the https:/
Mary Ann Liebert, Inc. 140 Huguenot Street, New Rochelle, NY 10801 http://www.
Phone: (914) 740-2100 (800) M-LIEBERT Fax (914) 740-2101
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.
Article originally posted at